Prophylactic Fibrinogen Reduces Excessive Bleeding in Total Hip Arthroplasty Surgery: A Randomized Double-blinded Placebo-controlled Trial
نویسندگان
1 Department of Orthopedic Surgery, Hualien Armed Forces General Hospital, Taiwan/Department of Orthopedic Surgery, National Defense Medical Center, Tri-Service General Hospital, Taipei, Taiwan
2 Clinical Research and Development Unit, Department of Anesthesiology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Department of anesthesiology, Shahid Beheshti University of Medical Science, Tehran, Iran
doi
10.22038/abjs.2023.74482.3450چکیده
We read with interest the article titled "Prophylactic Fibrinogen Reduces Excessive Bleeding in Total Hip Arthroplasty Surgery: A Randomized Double-blinded Placebo-controlled Trial" authored by Alireza Shakeri et al. with great interest. We commend the authors for their efforts to demonstrate the hemostatic effect of fibrinogen in total hip arthroplasty. However, we are concerned about the lack of clear criteria for postoperative blood transfusion in patients undergoing total hip arthroplasty, a crucial aspect that significantly influences the methodology of this study.
